1Wyatt R J,Julian BA.IgA nephropathy[J] .N Engl J Med,2013,368(25):2402-2414.
2Li X,Liu Y,Lv J,et al.Progression of IgA Nephropathy under Current Therapy Regimen in a Chinese Population[J] .Clin J Am Soc Nephrol,2014,9(3):484-489.
3Reich HN,Troyanov S,Scholey JW,et al.Remission of proteinuria improves prognosis in IgA nephropathy[J] .J Am Soc Nephrol,2007,18(12):3177-3183.
4Le W,Liang S,Hu Y,et al.Long-term renal survival and related risk factors in patients with IgA nephropathy:results from a cohort of 1155 cases in a Chinese adult population[J] .Nephrol Dial Transplant,2012,27 (4):1479-1485.
5Lv J,Ehteshami P,Sarnak M J,et al.Effects of intensive blood pressure lowering on the progression of chronic kidney disease:a systematic review and meta-analysis[J] .CMAJ,2013,185 (11):949-957.
6Lv J,Shi S,Xu D,et al.Evaluation of the Oxford Classification of IgA nephropathy:a systematic review and meta-analysis[J] .Am J Kidney Dis,2013,62 (5):891-899.
7Szeto CC,Lai FM,To KF,et al.The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria[J] .Am J Med,2001,110(6):434-437.
8van Vark LC,Bertrand M,Akkerhuis KM,et al.Angiotensin-converting enzyme inhibitors reduce mortality in hypertension:a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients[J] .Eur Heart J,2012,33 (16):2088-2097.
9Gutierrez E,Zamora I,Ballarin JA,et al.Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria[J] .J Am Soc Nephrol,2012,23 (10):1753-1760.
10Zhao N,Hou P,Lv J,et al.The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression[J] .Kidney Int,2012,82 (7):790-796.
